… of $502.6m during the first half (July/December 2024) … by increased purchases of wheat, pharmaceuticals, gauze pads, vaccines, soya … positive note for services, tourism revenues increased by 12.4% to … $252.8m in the first half of the previous fiscal year …

… year compared to the first half due to anticipated order … potential future pharmaceutical tariffs. BioMarin’s increasing profitability continues to … revenue in the second half of 2025 compared to the first half … larger than H1 and also the revenue and the …

… Transcript May 1, 2025 Phathom Pharmaceuticals, Inc. misses on earnings … when we go profitable depends on what the revenue ramp into 2026 … And I will do the first half of that regarding sort of … through that. Well, in the first half of it, we are simply …

… May 1, 2025 X4 Pharmaceuticals, Inc. beats earnings … a leading European specialty pharmaceutical company to commercialize … rare, another specialty pharmaceutical company to commercialize XOLREMDI … the first half of 2026. We reported net XOLREMDI revenues …

… 2025       2024   Revenues:       Product revenues, net $ 2,760.2 … 690.6   Other revenues   10.0       —   Total revenues   2,770.2 …   261.1     Vertex Pharmaceuticals Incorporated Total Revenues (unaudited, in millions)     … in the first half of 2026, beliefs …

… Thursday reported first-quarter profit and sales that beat Wall … and missed that deadline. Drugmakers have also been grappling with … to launch a probe into pharmaceutical imports that sets the … predicted revenue for 2025 to come in during the first half of …

… its 2025 financial guidance of revenue ranging between $1.5 billion … that President Trump’s proposed pharmaceutical tariffs “have not had a … business as usual through the first half of this year.” R…

… -CM in the first half of 2025. Alnylam … GAAP Operating income5   Achieve profitability       1Assumes approvals … revenues, Rare net product revenues, total net product revenues, and net revenues … PHARMACEUTICALS, INC. RECONCILIATION OF GAAP TO NON-GAAP PRODUCT REVENUE …

… on Thursday reported first-quarter profit and sales that beat Wall … and missed that deadline. Drugmakers have also been grappling with … to launch a probe into pharmaceutical imports that sets the … predicted revenue for 2025 to come in during the first half of …

… in the first half of 2026. Ex- … the first half of 2026. Revenue and Cost of Revenue: … ,865     $ —   Product revenue, net     942       —   Total revenue     28,807       …       6,666   X4 PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS …